[Skip to Content]
[Skip to Content Landing]
Editorial
February 13, 2018

Screening for Ovarian Cancer in Asymptomatic Women

Author Affiliations
  • 1Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houson
JAMA. 2018;319(6):557-558. doi:10.1001/jama.2017.21894

Developing an effective strategy for early detection of ovarian cancer remains one of the most significant unmet needs in the diagnosis and treatment of the disease. Approximately 22 000 cases of ovarian cancer are diagnosed each year among women in the United States.1 Similar to women with lung and pancreatic cancers, women with ovarian cancer are typically diagnosed in late stages, resulting in poor outcomes. For the 20% of patients with ovarian cancer diagnosed with stage I disease, 5-year survival rates are greater than 90%, whereas for the majority of women diagnosed with stage III or IV ovarian cancer, 5-year survival rates are approximately 17% to 39%.2

×